Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies
Clinical trial NCT02109445 · TERMINATED
Trial details
- NCT number
- NCT02109445
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-03
- Primary completion
- 2014-11-06
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.